Dongzhimen hospital affiliated to Bejing University of Chinese Medicine
Beijing, Beijing Municipality, China
NCT Number: NCT03966248
Knee osteoarthritis (KOA) is one of the most common musculoskeletal diseases in clinic. It usually occurs in middle-aged people, especially women. An estimated lifetime risk for KOA is approximately 40% in men and 47% in women. KOA is a chronic disease which can lead to obvious pain, joint stiffness, limitation of activity and even disability, with significant associated costs and effects on society, health systems, and individuals. Tuina therapy has been used and showed effectiveness and safety for pain relief and disability for the patients with musculoskeletal disorders for years in China. Though it is regarded that the Traditional Chinese medicine (TCM) Tuina therapy is similar to the modern manual therapies, the modalities of TCM tuina therapy are different and effect maybe equal to or more better than the modern manual therapy in clinic. However, little evidence exists that Tuina benefits the KOA. The investigators will do this in a randomized, parallel, active controlled study to observe whether TCM Tuina is more beneficial to KOA than the physical manual therapy, which has been considered an effective and standard care for KOA.
Looking for future studies?
Notify Me40 year–75 year
All sexes
Interventional
Not applicable
Beijing, Beijing Municipality, China
Patients will be randomly allocated to one of two groups. In the Chinese Tuina group (group CTG), patients will receive the traditional Chinese Tuina therapy (including rolling, grasping, scratching, pressing, acupressure or pushing) on the basis of KOA health education and home-exercise. Patients in the Physical Manual group (group PMG) will receive the modern physical manual therapy (including joint mobilization/manipulation, manual traction, soft tissue manipulations, passive stretching, range of motion and strength training) on the basis of KOA health education and home-exercise. Assessments will be conducted at baseline and 4 and 16 weeks after randomization.
It is expected that the interventions will alleviate the sufferings of the patient. The risks of participation are minimal. Occasionally, tuina can make people feel nauseous or experience a temporary increase in pain either during or after treatment. Rare side effects happen during and after Tuina or manual treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This group receives 8 treatments over a 3 week period with a one week follow-up on site and a 3 month follow-up by mail, phone or email.
This group receives 8 treatments over a 3 week period with a one week follow-up on site and a 3 month follow-up by mail, phone or email.
Time frame: Change from baseline at 4 weeks
Self report measure of pain, stiffness, and physical function for people with knee osteoarthritis.
Time frame: Change from baseline at 8 weeks and 16 weeks
Self report measure of pain, stiffness, and physical function for people with knee osteoarthritis.
Time frame: Change from baseline at 4 weeks, 8 weeks and 16 weeks
Subjects will rate their worst knee pain in the last 24 hours using an 11 point numeric pain rating scale with 0 representing "no pain" and 10 representing " the worst pain imaginable".
Time frame: Change from baseline at 4 weeks, 8 weeks and 16 weeks
The Patient global assessment rating is a 11 point Numeric Rating Scale in which subjects will rate the degree to which their knee condition has changed from the time treatment was initiated to the present. The subject responds to the following query: "Please rate your overall knee's condition from the time you began treatment until now." using an 11 point numeric rating scale with 0 representing "A very great deal better" and 10 representing "A very great deal worse".
Time frame: Change from baseline at 4 weeks, 8 weeks and 16 weeks
The SF-12 is a generic health-related quality of life measure.
Time frame: Change from baseline at 4 weeks
Subjects will be seated with their arms crossed in front of their chest. On the command "go" subjects will stand up and sit down for as many trials as they can in a 30 second period.
Time frame: Change from baseline at 4 weeks
On the command "go" subjects will stand up from a chair, walk 3 meters, turn around, return to the chair and sit down. The time it takes to complete this task will be recorded.
Time frame: Change from baseline at 4 weeks
One single-leg standing was assessed balance. Test required the subject to stand with arms by his/her side.Timing was started when the subject raised one foot off the ground. Timing was stopped if the subject displaced the weight-bearing foot, touched the suspended foot to the ground, used the suspended limb to support the weight-bearing limb, or reached the maximum balance time of 30 seconds.
Time frame: At weeks 4 after randomisation.
Responder criteria included 1) greater than or equal to 50% improvement in WOMAC pain or WOMAC function and an absolute improvement of greater than or equal to 20, or 2) improvement in at least 2 of the following 3 scores: 20% improvement in pain and absolute change ≥ 10 on WOMAC pain score, 20% improvement in pain and absolute change ≥ 10 on WOMAC function score, or moderate or greater improvement (≤ 4) on a 15 point global rating of change scale
Time frame: At weeks 4 after randomisation.
To test whether the participants are blinded successfully, all participants will be asked to guess which kind of treatment they received.
Time frame: About 5 min after the first treatment
The credibility and expectancy of participants will be measured using the Credibility/Expectancy Questionnaire
Time frame: At weeks 4, 8 and 16 after randomisation.
Any use of pain-killers will be ascertained.
Time frame: At weeks 4 after randomisation.
Adverse Event Form
Beijing University of Chinese Medicine
Other
Chinese Tuina (Chinese Massage and Manipulation Therapy) for KOA: A Randomized, Parallel, Physical Therapies Active Controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02944448
Arthritis, Connective Tissue Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT00992004
Arthritis, Connective Tissue Diseases
Créteil, France
View Trial DetailsNCT06173193
Arthritis, Behavior
Jyväskylä, Finland
View Trial DetailsNCT04906499
Anterior Cruciate Ligament Injuries, Arthritis
Chapel Hill, North Carolina, United States
View Trial Details